Sms Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is FAMOTIDINE USP, with a corresponding US DMF Number 21442.
Remarkably, this DMF maintains an Active status since its submission on March 20, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 14, 2014, and payment made on August 30, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II